Mechanisms for the activity of heterocyclic cyclohexanone curcumin derivatives in estrogen receptor negative human breast cancer cell lines

By Somers-Edgar Tiffany   Taurin Sebastien   Larsen Lesley   Chandramouli Anupama   Nelson Mark   Rosengren Rhonda  

Investigational New Drugs, Vol. 29, Iss. 1, 2011-02 ,pp. : 87-97

Springer Publishing Company

Access to resources Recommend Favorite

Synthesis and Antiproliferative Activity of Coumarin-Estrogen Conjugates against Breast Cancer Cell Lines

By  

Letters in Drug Design & Discovery, Vol. 6, Iss. 2, 2009-03 ,pp. : 133-138

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis of Some Coumarinyl Chalcones and their Antiproliferative Activity Against Breast Cancer Cell Lines

By  

Letters in Drug Design & Discovery, Vol. 8, Iss. 4, 2011-05 ,pp. : 308-311

Bentham Science Publishers

Access to resources Recommend Favorite

The 4′-O-benzylated doxorubicin analog WP744 overcomes resistance mediated by P-glycoprotein, multidrug resistance protein and breast cancer resistance protein in cell lines and acute myeloid leukemia cells

By Brooks Tracy   O’Loughlin Kieran   Minderman Hans   Bundy Brian   Ford Laurie   Vredenburg Michael   Bernacki Ralph   Priebe Waldemar   Baer Maria  

Investigational New Drugs, Vol. 25, Iss. 2, 2007-04 ,pp. : 115-122

Springer Publishing Company

Access to resources Recommend Favorite

Breast cancer cell response to calcitonin: Modulation by growth-regulating agents

By Lacroix M.   Siwek B.   Body J.-J.  

European Journal of Pharmacology, Vol. 344, Iss. 2, 1998-03 ,pp. : 279-286

Elsevier

Access to resources Recommend Favorite